The University of Chicago Header Logo

The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.

The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now. J Clin Oncol. 2019 08 20; 37(24):2177-2178.

View in: PubMed